Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 123

1.

[Designer drug induced psychosis].

Fullajtar M, Ferencz C.

Neuropsychopharmacol Hung. 2012 Jun;14(2):137-40. Hungarian.

PMID:
22710853
[PubMed - indexed for MEDLINE]
Free Article
2.

[Clinical characteristics of 5 hospitalized 3,4-methylenedioxypyrovalerone (MDPV) users].

Farkas K, Sirály E, Szily E, Csukly G, Réthelyi J.

Psychiatr Hung. 2013;28(4):431-9. Hungarian.

PMID:
24443577
[PubMed - indexed for MEDLINE]
3.

[3,4-methylene-dioxy-pyrovalerone (MDPV) epidemic?].

Kalapos MP.

Orv Hetil. 2011 Dec 11;152(50):2010-9. doi: 10.1556/OH.2011.29259. Review. Hungarian.

PMID:
22112374
[PubMed - indexed for MEDLINE]
4.

Psychosis from a bath salt product containing flephedrone and MDPV with serum, urine, and product quantification.

Thornton SL, Gerona RR, Tomaszewski CA.

J Med Toxicol. 2012 Sep;8(3):310-3. doi: 10.1007/s13181-012-0232-4.

PMID:
22528592
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Transition to injecting 3,4-methylene-dioxy-pyrovalerone (MDPV) among needle exchange program participants in Hungary.

Csák R, Demetrovics Z, Rácz J.

J Psychopharmacol. 2013 Jun;27(6):559-63. doi: 10.1177/0269881113480987. Epub 2013 Mar 4.

PMID:
23459086
[PubMed - indexed for MEDLINE]
6.

Illicit bath salts: not for bathing.

Kyle PB, Iverson RB, Gajagowni RG, Spencer L.

J Miss State Med Assoc. 2011 Dec;52(12):375-7.

PMID:
22329114
[PubMed - indexed for MEDLINE]
7.

The novel recreational drug 3,4-methylenedioxypyrovalerone (MDPV) is a potent psychomotor stimulant: self-administration and locomotor activity in rats.

Aarde SM, Huang PK, Creehan KM, Dickerson TJ, Taffe MA.

Neuropharmacology. 2013 Aug;71:130-40. doi: 10.1016/j.neuropharm.2013.04.003. Epub 2013 Apr 15.

PMID:
23597511
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

3,4-methylenedioxypyrovalerone (MDPV): chemistry, pharmacology and toxicology of a new designer drug of abuse marketed online.

Coppola M, Mondola R.

Toxicol Lett. 2012 Jan 5;208(1):12-5. doi: 10.1016/j.toxlet.2011.10.002. Epub 2011 Oct 8. Review.

PMID:
22008731
[PubMed - indexed for MEDLINE]
9.

Hallucinatory delirium following use of MDPV: "Bath Salts".

Penders TM, Gestring R.

Gen Hosp Psychiatry. 2011 Sep-Oct;33(5):525-6. doi: 10.1016/j.genhosppsych.2011.05.014. Epub 2011 Jul 16. No abstract available.

PMID:
21762997
[PubMed - indexed for MEDLINE]
10.

New designer drug of abuse: 3,4-Methylenedioxypyrovalerone (MDPV). Findings from apprehended drivers in Finland.

Kriikku P, Wilhelm L, Schwarz O, Rintatalo J.

Forensic Sci Int. 2011 Jul 15;210(1-3):195-200. doi: 10.1016/j.forsciint.2011.03.015. Epub 2011 Apr 7.

PMID:
21477955
[PubMed - indexed for MEDLINE]
11.

2C-T-4 intoxication: acute psychosis caused by a designer drug.

Miyajima M, Matsumoto T, Ito S.

Psychiatry Clin Neurosci. 2008 Apr;62(2):243. doi: 10.1111/j.1440-1819.2008.01764.x. No abstract available.

PMID:
18412852
[PubMed - indexed for MEDLINE]
12.

Bath salts: they are not what you think.

Wieland DM, Halter MJ, Levine C.

J Psychosoc Nurs Ment Health Serv. 2012 Feb;50(2):17-21.

PMID:
22439144
[PubMed - indexed for MEDLINE]
13.

Urine analysis of 3,4-methylenedioxypyrovalerone in opioid-dependent patients by gas chromatography-mass spectrometry.

Ojanperä IA, Heikman PK, Rasanen IJ.

Ther Drug Monit. 2011 Apr;33(2):257-63. doi: 10.1097/FTD.0b013e318208b693.

PMID:
21240056
[PubMed - indexed for MEDLINE]
14.

Designer drugs in psychiatric practice - a review of the literature and the recent situation in Hungary.

Szily E, Bitter I.

Neuropsychopharmacol Hung. 2013 Dec;15(4):223-31. Review.

PMID:
24380963
[PubMed - indexed for MEDLINE]
Free Article
15.

Postmortem tissue distribution of MDPV following lethal intoxication by "bath salts".

Wyman JF, Lavins ES, Engelhart D, Armstrong EJ, Snell KD, Boggs PD, Taylor SM, Norris RN, Miller FP.

J Anal Toxicol. 2013 Apr;37(3):182-5. doi: 10.1093/jat/bkt001. Epub 2013 Feb 13.

PMID:
23408250
[PubMed - indexed for MEDLINE]
16.

Analysis of MDPV in blood--determination and interpretation.

Adamowicz P, Gil D, Skulska A, Tokarczyk B.

J Anal Toxicol. 2013 Jun;37(5):308-12. doi: 10.1093/jat/bkt025. Epub 2013 Apr 8.

PMID:
23572248
[PubMed - indexed for MEDLINE]
17.

Simultaneous detection of multiple designer drugs in serum, urine, and CSF in a patient with prolonged psychosis.

Thornton SL, Lo J, Clark RF, Wu AH, Gerona RR.

Clin Toxicol (Phila). 2012 Dec;50(10):1165-8. doi: 10.3109/15563650.2012.744996. Epub 2012 Nov 20.

PMID:
23163617
[PubMed - indexed for MEDLINE]
18.

Acute psychosis following ingestion of 'Rapture'.

Austin H, Monasterio E.

Australas Psychiatry. 2004 Dec;12(4):406-8.

PMID:
15715818
[PubMed - indexed for MEDLINE]
19.

A case of acute agitation with a negative urine drug screen: a new wave of "legal" drugs of abuse.

Kadaria D, Sinclair SE.

Tenn Med. 2012 Oct;105(9):31-2.

PMID:
23097956
[PubMed - indexed for MEDLINE]
20.

Toxicity and death following recreational use of 2-pyrrolidino valerophenone.

Eiden C, Mathieu O, Cathala P, Debruyne D, Baccino E, Petit P, Peyriere H.

Clin Toxicol (Phila). 2013 Nov;51(9):899-903. doi: 10.3109/15563650.2013.847187. Epub 2013 Oct 11.

PMID:
24111554
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk